Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$371M |
| 2 |
Citigroup
C
|
+$175M |
| 3 |
US Bancorp
USB
|
+$163M |
| 4 |
Lowe's Companies
LOW
|
+$162M |
| 5 |
Meta Platforms (Facebook)
META
|
+$149M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$249M |
| 2 |
Goldman Sachs
GS
|
+$228M |
| 3 |
Alibaba
BABA
|
+$162M |
| 4 |
Cemex
CX
|
+$157M |
| 5 |
Halliburton
HAL
|
+$155M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.11% |
| 2 | Consumer Discretionary | 12.23% |
| 3 | Healthcare | 10.85% |
| 4 | Technology | 7.76% |
| 5 | Real Estate | 6.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Jack Henry & Associates
JKHY
$12.3B
| $1.05M | ﹤0.01% |
+10,200
| New | +$1.06M |
|
|
DMK
1152
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $1.04M | ﹤0.01% |
+2,857
| New | +$1.01M |
|
1153
Yum! Brands
YUM
$42.6B
| $1.04M | ﹤0.01% |
14,157
-187,507
| -93% | -$14.1M |
|
|
XEC
1154
DELISTED
CIMAREX ENERGY CO
XEC
| $1.04M | ﹤0.01% |
9,169
+5,879
| +179% | +$587K |
|
1155
Corning
GLW
$127B
| $1.04M | ﹤0.01% |
34,700
-404,850
| -92% | -$12M |
|
1156
Nu Skin
NUS
$236M
| $1.03M | ﹤0.01% |
16,835
-45,626
| -73% | -$2.8M |
|
1157
Primerica
PRI
$9.16B
| $1.03M | ﹤0.01% |
12,612
-100
| -0.8% | -$7.81K |
|
|
APC
1158
DELISTED
Anadarko Petroleum
APC
| $1.03M | ﹤0.01% |
21,060
-47,109
| -69% | -$2.08M |
|
|
CTRA
1159
DELISTED
Coterra Energy
CTRA
| $1.02M | ﹤0.01% |
+38,160
| New | +$970K |
|
1160
John Wiley & Sons Class A
WLY
$2.74B
| $1.02M | ﹤0.01% |
+19,011
| New | +$1.02M |
|
|
ANSS
1161
DELISTED
Ansys
ANSS
| $1.02M | ﹤0.01% |
8,275
-873
| -10% | -$110K |
|
1162
Ford
F
$55.6B
| $1M | ﹤0.01% |
84,000
-502,000
| -86% | -$5.66M |
|
|
SRC
1163
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $997K | ﹤0.01% |
25,931
-105,989
| -80% | -$3.91M |
|
|
ITG
1164
DELISTED
Investment Technology Group Inc
ITG
| $995K | ﹤0.01% |
+44,951
| New | +$940K |
|
|
CCMP
1165
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $989K | ﹤0.01% |
12,378
+9,200
| +289% | +$678K |
|
1166
Central Pacific Financial
CPF
$969M
| $988K | ﹤0.01% |
30,711
+23,002
| +298% | +$696K |
|
1167
CALL
DexCom
DXCM
$33.6B
| $979K | ﹤0.01% |
+80,000
| New | +$1.41M |
|
|
1168
PUT
DexCom
DXCM
$33.6B
| $979K | ﹤0.01% |
+80,000
| New | +$1.41M |
|
1169
Avnet
AVT
$7.19B
| $978K | ﹤0.01% |
24,877
+17,366
| +231% | +$665K |
|
1170
National Healthcare
NHC
$3.52B
| $966K | ﹤0.01% |
+15,438
| New | +$995K |
|
|
PSTB
1171
DELISTED
Park Sterling Corp.
PSTB
| $966K | ﹤0.01% |
+77,786
| New | +$903K |
|
1172
Omnicom Group
OMC
$24.2B
| $964K | ﹤0.01% |
13,009
+110
| +0.9% | +$8.48K |
|
|
PAY
1173
DELISTED
Verifone Systems Inc
PAY
| $960K | ﹤0.01% |
47,331
-26,840
| -36% | -$524K |
|
|
OPLN
1174
Openlane
OPLN
$4.19B
| $959K | ﹤0.01% |
53,059
-1,181,851
| -96% | -$19.5M |
|
1175
Medtronic
MDT
$117B
| $957K | ﹤0.01% |
12,304
-568,783
| -98% | -$47.2M |
|
Similar funds
Dmitry Balyasny's Q3 2017 Portfolio in Review
As of Q3 2017, Dmitry Balyasny held 2,244 positions worth $25.5B, up 5.2% from $24.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Dmitry Balyasny's Q3 2017 filing shows 814 new, 508 increased, 495 reduced and 411 closed positions. Its largest new stake was Range Resources: 5,316,064 shares worth $104M. The largest sale was Bank of America, an estimated $249M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Dmitry Balyasny's largest Q3 2017 buy was Range Resources: 5,316,064 shares worth $104M.
- Dmitry Balyasny added most to JPMorgan Chase in Q3 2017, an estimated $371M increase.
- Dmitry Balyasny's biggest Q3 2017 reduction was Bank of America, cutting an estimated $249M.
- Dmitry Balyasny fully exited Cemex in Q3 2017, selling an estimated $157M.
- Dmitry Balyasny's ten largest holdings make up 11% of its $25.5B portfolio in Q3 2017.
- Dmitry Balyasny opened 814 new positions and closed 411 in Q3 2017.
- Dmitry Balyasny's portfolio value rose 5.2% quarter-over-quarter to $25.5B.
Based on Balyasny Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.